158 related articles for article (PubMed ID: 15043529)
21. [Activated protein C resistance--a recently discovered hereditary thrombophilia].
Moland L; Sandset PM
Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3590-5. PubMed ID: 9820002
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.
Mikovic D; Rakicevic L; Kovac M; Radojkovic D
Thromb Haemost; 2000 Oct; 84(4):723-4. PubMed ID: 11057877
[No Abstract] [Full Text] [Related]
23. Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screening.
Middeldorp S; van der Meer J
Semin Thromb Hemost; 1998; 24(4):363-6. PubMed ID: 9763353
[TBL] [Abstract][Full Text] [Related]
24. The VITA project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Vicenza Thrombophilia and Atherosclerosis.
Tosetto A; Missiaglia E; Gatto E; Rodeghiero F
Thromb Haemost; 1997 Aug; 78(2):859-63. PubMed ID: 9268185
[TBL] [Abstract][Full Text] [Related]
25. In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity.
Santacroce R; Bossone A; Brancaccio V; Fortina P; Margaglione M
Thromb Haemost; 2000 Jun; 83(6):963-4. PubMed ID: 10896257
[No Abstract] [Full Text] [Related]
26. Anterior ischemic optic neuropathy and activated protein C resistance. A case report and review of the literature.
Worrall BB; Moazami G; Odel JG; Behrens MM
J Neuroophthalmol; 1997 Sep; 17(3):162-5. PubMed ID: 9304527
[TBL] [Abstract][Full Text] [Related]
27. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of factor V Leiden in the Chinese population.
Ho CH; Chau WK; Hsu HC; Gau JP; Chih CM
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Dec; 62(12):875-8. PubMed ID: 10634001
[TBL] [Abstract][Full Text] [Related]
29. Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.
Morange PE; Aillaud MF; Nicaud V; Henry M; Juhan-Vague I
Thromb Haemost; 2001 Dec; 86(6):1583-4. PubMed ID: 11776333
[No Abstract] [Full Text] [Related]
30. The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan.
Kobashi G; Yamada H; Asano T; Nagano S; Hata A; Kishi R; Kondo K; Fujimoto S
Semin Thromb Hemost; 1999; 25(5):487-9. PubMed ID: 10625207
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
[No Abstract] [Full Text] [Related]
32. The impact of factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions.
Sampram ES; Lindblad B
Eur J Vasc Endovasc Surg; 2001 Aug; 22(2):134-8. PubMed ID: 11472046
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death.
Rothbart H; Ohel G; Younis J; Lanir N; Brenner B
J Matern Fetal Med; 1999; 8(5):228-30. PubMed ID: 10475506
[TBL] [Abstract][Full Text] [Related]
34. Factor V Arg306 --> Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese.
Shen MC; Lin JS; Tsay W
Thromb Haemost; 2001 Feb; 85(2):270-3. PubMed ID: 11246546
[TBL] [Abstract][Full Text] [Related]
35. Inherited Thrombophilia due to Factor V Leiden Mutation.
Mattson JC; Crisan D
Mol Diagn; 1998 Mar; 3(1):55-61. PubMed ID: 10096958
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary fibrosis is increased in mice carrying the factor V Leiden mutation following bleomycin injury.
Xu Z; Westrick RJ; Shen YC; Eitzman DT
Thromb Haemost; 2001 Mar; 85(3):441-4. PubMed ID: 11307811
[TBL] [Abstract][Full Text] [Related]
37. Resistance to activated protein C: a major cause of inherited thrombophilia.
Jensen R; Ens GE
Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
[TBL] [Abstract][Full Text] [Related]
38. [Study of activated protein C resistance(APC-R) and FV Leiden in healthy blood donors and patients with thrombosis].
Hong M; Wei W; Song S
Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):455-7. PubMed ID: 11189481
[TBL] [Abstract][Full Text] [Related]
39. Reversal of nonarteritic anterior ischemic optic neuropathy associated with coexisting primary antiphospholipid syndrome and Factor V Leiden mutation.
Srinivasan S; Fern A; Watson WH; McColl MD
Am J Ophthalmol; 2001 May; 131(5):671-3. PubMed ID: 11336954
[TBL] [Abstract][Full Text] [Related]
40. [Mutation of factor V Leiden and chronic leg edema with chronic venous insufficiency and recurrent thromboses].
Chanda RA
Praxis (Bern 1994); 1999 Sep; 88(36):1449-50. PubMed ID: 10500421
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
